| Capital Research Global Investors |
| 5.3M |
| $199.2M |
| +3.5% |
| 6.083% |
| 0.03% |
| 5 | BAKER BROS. ADVISORS LP | 5.0M | $186.7M | +27.0% | 5.702% | 0.94% |
| 6 | STATE STREET CORP | 4.5M | $169.5M | +20.3% | 5.177% | 0.00% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $154.0M | +10.7% | 4.704% | 0.00% |
| 8 | Logos Global Management LP | 3.0M | $111.8M | -13.0% | 3.415% | 4.81% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.7M | $101.2M | -3.8% | 3.091% | 0.14% |
| 10 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.7M | $101.2M | +77.4% | 3.089% | 1.06% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $90.4M | -3.0% | 2.761% | 0.00% |
| 12 | MORGAN STANLEY | 1.9M | $72.0M | +3.8% | 2.198% | 0.00% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $61.9M | +24.6% | 1.891% | 0.01% |
| 14 | ALLIANCEBERNSTEIN L.P. | 1.6M | $54.2M | +1514.8% | 1.852% | 0.02% |
| 15 | Fiera Capital Corp | 1.4M | $53.9M | -42.8% | 1.646% | 0.20% |
| 16 | FEDERATED HERMES, INC. | 1.4M | $53.4M | -52.1% | 1.629% | 0.08% |
| 17 | GSK plc | 1.3M | $49.7M | 0.0% | 1.517% | 8.25% |
| 18 | BNP Paribas Asset Management Holding S.A. | 1.3M | $47.3M | +15.3% | 1.445% | 0.05% |
| 19 | GOLDMAN SACHS GROUP INC | 1.2M | $45.9M | -35.6% | 1.402% | 0.00% |
| 20 | Candriam S.C.A. | 1.1M | $40.7M | -1.4% | 1.243% | 0.18% |
| 21 | BANK OF AMERICA CORP /DE/ | 1.0M | $38.2M | +8.9% | 1.168% | 0.00% |
| 22 | Sofinnova Investments, Inc. | 925K | $34.5M | -18.3% | 1.053% | 1.78% |
| 23 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 892K | $33.2M | — | 1.015% | 0.01% |
| 24 | Fisher Asset Management, LLC | 851K | $31.7M | -3.6% | 0.969% | 0.01% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 822K | $30.6M | +10.2% | 0.935% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in IDYA — a direct measure of their conviction.
| 105.38% |
| +1.22 pp |
| $1.44B |
| 34% |
| Q4 2024 | 204 | 0.5% | 104.16% | 0.93 pp | $2.19B | 19% |
| Q3 2024 | 205 | — | 105.09% | — | $2.71B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
IDYA institutional ownership rose by 6.71 percentage points quarter-over-quarter, with a net change of +32 holders.
The top 10 institutions account for 59.0% of all reported 13F value in IDYA, and the top 25 account for 78.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
IDEAYA Biosciences, Inc. (IDYA) Institutional Ownership